Snapshot from Jul 07, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Governments / India — Drugs Technical Advisory Board
Entity

India — Drugs Technical Advisory Board

Tracked across 3 events · 20 articles · First seen Dec 31, 2025 · Last active Jun 28, 2026

Sentiment
27
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (3)
2 20
Regulatory
India OTC Nicotine Therapy Access
Impact: The India — Drugs Technical Advisory Board is urged by public health experts to maintain over-the-counter access for 2 mg and 4 mg nicotine replacement therapies.
May 07, 2026 · 7 articles
4 10
Regulatory
India Bans High-Dose Nimesulide
Impact: The India — Drugs Technical Advisory Board was consulted before the ban on high-dose Nimesulide was implemented, indicating its role in drug regulation.
Dec 31, 2025 · 7 articles
4 50
Regulatory
India Medical Device Licensing Streamlined
Impact: The India — Drugs Technical Advisory Board provided suggestions that formed the basis for the draft notification of the amendments to the Medical Devices Rules, 2017.
Jun 28, 2026 · 6 articles
ERGEN INTELLIGENCE
Track India — Drugs Technical Advisory Board live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.